U.S. flag

An official website of the United States government

NM_003193.5(TBCE):c.100+13TG[25] AND Hypoparathyroidism-retardation-dysmorphism syndrome

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Jun 14, 2016
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000310092.5

Allele description [Variation Report for NM_003193.5(TBCE):c.100+13TG[25]]

NM_003193.5(TBCE):c.100+13TG[25]

Gene:
TBCE:tubulin folding cofactor E [Gene - OMIM - HGNC]
Variant type:
Microsatellite
Cytogenetic location:
1q42.3
Genomic location:
Preferred name:
NM_003193.5(TBCE):c.100+13TG[25]
HGVS:
  • NC_000001.11:g.235380163GT[25]
  • NG_009230.1:g.17751GT[25]
  • NM_001079515.3:c.100+13TG[25]
  • NM_001287801.2:c.100+13TG[25]
  • NM_001287802.2:c.-211+13TG[25]
  • NM_003193.5:c.100+13TG[25]MANE SELECT
  • NC_000001.10:g.235543477_235543478del
  • NC_000001.10:g.235543478GT[25]
  • NM_003193.3:c.100+64_100+65delGT
Links:
dbSNP: rs10524346
NCBI 1000 Genomes Browser:
rs10524346
Molecular consequence:
  • NM_001079515.3:c.100+13TG[25] - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001287801.2:c.100+13TG[25] - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001287802.2:c.-211+13TG[25] - intron variant - [Sequence Ontology: SO:0001627]
  • NM_003193.5:c.100+13TG[25] - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:
Hypoparathyroidism-retardation-dysmorphism syndrome (HRDS)
Synonyms:
Sanjad-Sakati syndrome; HRD syndrome; Hypoparathyroidism with short stature, mental retardation and seizures; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0009426; MedGen: C1855840; Orphanet: 2323; OMIM: 241410

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000355628Illumina Laboratory Services, Illumina
criteria provided, single submitter

(ICSL Variant Classification 20161018)
Uncertain significance
(Jun 14, 2016)
germlineclinical testing

ICSL_Variant_Classification_20161018.pdf,

Citation Link,

SCV000355629Illumina Laboratory Services, Illumina
criteria provided, single submitter

(ICSL Variant Classification 20161018)
Uncertain significance
(Jun 14, 2016)
germlineclinical testing

ICSL_Variant_Classification_20161018.pdf

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Illumina Laboratory Services, Illumina, SCV000355628.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Illumina Laboratory Services, Illumina, SCV000355629.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024